ArticleCrohn's & colitis 3602026

Real-world effectiveness of guselkumab for induction of remission in Crohn's disease: a prospective multicenter cohort study with propensity score-matched comparison to risankizumab.

Maitha Al Hosani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.